Related Experiment Videos
Changes in total serum glycosaminoglycan levels in patients undergoing renal transplantation: preliminary data
Eleni G Papaioannou1, Christina Magkou, Alkiviadis Kostakis
1Department of Experimental Pharmacology, Medical School, University of Athens, 75 Mikras Asias Street, Athens 115 27, Greece.
Purpose:
To study the involvement of glycosaminoglycans (GAGs) in the immunological process of renal disease. They are related to cytokines, which are known to play an important role in acute graft rejection after renal transplantation.
Methods:
We studied 40 patients on maintenance hemodialysis for chronic renal failure, who underwent renal transplantation from a live donor. We measured serum GAGs preoperatively, intraoperatively, and on postoperative days (PODs) 2 and 10. The clinical outcome and other biochemical markers, such as blood urea nitrogen and serum creatinine, were also recorded.
Results:
The total serum GAG levels decreased after renal transplantation in patients with normal graft function (group N). However, in patients with acute graft rejection post-transplantation (group R), the GAG levels remained significantly elevated.
Conclusions:
Total serum GAGs fluctuate in renal transplantation and their association with graft rejection should be investigated further.
Related Concept Videos
Proteoglycans
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Kidney Transplant III: Nursing Management
Serum Studies: Renal Function Tests